Efficacy and Safety of Acotiamide in Functional Dyspepsia: Meta-Analysis of Randomized Controlled Trials (ACG 2026) - Aug 29, 2026 - Abstract #P4421; Pres time: Oct 12, 2026; 10:30 AM - 04:15 PM; Location: Exhibit Halls A - D (Level 3); "Six RCTs (n â 1,697) were included. Acotiamide was more effective than placebo in improving global functional dyspepsia (FD) symptoms (RR = 1.29, 95% CI: 1.19â1.40; p < 0.00001; I² = 15%). Subgroup analysis demonstrated that efficacy significantly favored acotiamide in postprandial distress syndrome (PDS) symptoms (RR = 1.29, 95% CI: 1.09â1.53), but not in epigastric pain syndrome (EPS) (RR = 0.92, 95% CI: 0.76â1.11)."
Retrospective data • Dyspepsia • Musculoskeletal Pain
|
|
Farhan Murtaza MD 1; Umer Irshad MD 2; Muhammad Abdullah MBBS 3; Muhammad Junaid. Azhar MD 4; Ahsan Ullah MD 5; Yves Mrad MD 6; Bacel Nseir MD 2; Manish Rungta MD 7
|